Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | YM-254890 |
Trade Name | |
Synonyms | YM254890|YM 254890 |
Drug Descriptions |
YM-254890 is a specific inhibitor of the G protein-coupled receptor, Gq (PMID: 31539242), that inhibits the exchange reaction of GDP/GTP by inhibiting the release of GDP (PMID: 20639466), and may lead to inhibition of cell proliferation and tumor formation (PMID: 33229459). |
DrugClasses | |
CAS Registry Number | 568580-02-9 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Alpelisib + YM-254890 | Alpelisib YM-254890 | 0 | 0 |
AXL1717 + YM-254890 | AXL1717 YM-254890 | 0 | 0 |
Binimetinib + YM-254890 | Binimetinib YM-254890 | 0 | 0 |
Linsitinib + YM-254890 | Linsitinib YM-254890 | 0 | 0 |
Trametinib + YM-254890 | Trametinib YM-254890 | 1 | 0 |
YM-254890 | YM-254890 | 3 | 0 |